The United States diabetes market expands due to increasing patient numbers, lifestyle-related risk factors, and advanced diagnostic and treatment technologies. Growth is supported by demand for monitoring devices, medications, insulin delivery systems, digital health tools, and preventive care programs aimed at improving long-term disease management outcomes. https://www.imarcgroup.com/us-diabetes-market